GAMMA Investing
SION icon

GAMMA Investing’s Sionna Therapeutics SION Stock Holding History

GAMMA Investing’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.87K Buy
925
+681
+279% +$15.6K ﹤0.01% 3658
2026
Q2 		$10.7K Buy
244
+6
+3% +$240 ﹤0.01% 3171
2026
Q1 		$9.5K Buy
238
+61
+34% +$2.33K ﹤0.01% 3090
2025
Q4 		$7.28K Buy
177
+24
+16% +$910 ﹤0.01% 3120
2025
Q3 		$4.5K Buy
+153
New +$3.33K ﹤0.01% 3216

Other funds holding SION

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
True Wealth Design
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
Owl Creek Wealth Partners
Owl Creek Wealth Partners Denver, Colorado $355M AUM
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Contravisory Investment Management
Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return

GAMMA Investing's SION Position: Q3 2026 in Review

GAMMA Investing increased its Sionna Therapeutics (SION) stake by 279% in Q3 2026, buying an estimated $15.6K and bringing the position to 925 shares worth $4.87K. The position accounts for ﹤0.01% of the portfolio, ranked #3658.

GAMMA Investing first reported a position in SION in Q3 2025 and has held it in 5 quarters since. The position peaked at $10.7K in Q2 2026. 11 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • GAMMA Investing held 925 shares of Sionna Therapeutics worth $4.87K as of Q3 2026.
  • GAMMA Investing bought 681 Sionna Therapeutics shares in Q3 2026, an estimated $15.6K.
  • Sionna Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3658 holding.
  • GAMMA Investing first reported a position in Sionna Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • GAMMA Investing's Sionna Therapeutics position peaked at $10.7K in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.